Detailed information for compound 308391

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 305.329 | Formula: C15H19N3O4
  • H donors: 3 H acceptors: 3 LogP: 1.79 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCNC(=O)Nc1c(O)nc(c2c1cc(OC)c(c2)OC)C
  • InChi: 1S/C15H19N3O4/c1-5-16-15(20)18-13-10-7-12(22-4)11(21-3)6-9(10)8(2)17-14(13)19/h6-7H,5H2,1-4H3,(H,17,19)(H2,16,18,20)
  • InChiKey: ATDTUAGLDGSQEC-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium ulcerans hypothetical protein 0.0046 1 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0033 0.5844 0.5844
Entamoeba histolytica acyl-CoA synthetase, putative 0.0046 1 1
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0035 0.6421 0.5
Leishmania major 4-coumarate:coa ligase-like protein 0.0046 1 1
Toxoplasma gondii propionate-CoA ligase 0.0014 0 0.5
Trypanosoma brucei long-chain-fatty-acid-CoA ligase, putative 0.0014 0 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0046 1 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0046 1 1
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0035 0.6421 0.6421
Trypanosoma cruzi acetyl-CoA synthetase, putative 0.0014 0 0.5
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0046 1 1
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0035 0.6421 0.6421
Mycobacterium ulcerans acyl-CoA synthetase 0.0046 1 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0033 0.5844 0.5844
Brugia malayi AMP-binding enzyme family protein 0.0046 1 1
Plasmodium falciparum acyl-CoA synthetase 0.0035 0.6421 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.6421 0.6421
Trypanosoma cruzi long-chain-fatty-acid-CoA ligase, putative 0.0014 0 0.5
Leishmania major 4-coumarate:coa ligase-like protein 0.0046 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.6421 0.6421
Toxoplasma gondii AMP-binding enzyme domain-containing protein 0.0014 0 0.5
Plasmodium vivax acyl-CoA synthetase, putative 0.0035 0.6421 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0033 0.5844 0.5844
Loa Loa (eye worm) hypothetical protein 0.0046 1 1
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0046 1 1
Schistosoma mansoni acetyl-CoA synthetase 0.0014 0 0.5
Entamoeba histolytica acyl-CoA synthetase, putative 0.0046 1 1
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0046 1 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0033 0.5844 0.5844
Trypanosoma brucei acetyl-CoA synthetase, putative 0.0014 0 0.5
Onchocerca volvulus 0.0046 1 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0046 1 1
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0046 1 1
Trichomonas vaginalis antibiotic synthetase, putative 0.0014 0 0.5
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0046 1 1
Brugia malayi AMP-binding enzyme family protein 0.0046 1 1
Entamoeba histolytica acyl-coA synthetase, putative 0.0046 1 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0046 1 1
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0046 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.6421 0.6421
Loa Loa (eye worm) hypothetical protein 0.0046 1 1
Echinococcus multilocularis acetyl coenzyme A synthetase, cytoplasmic 0.0014 0 0.5
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0046 1 1
Trypanosoma cruzi acetyl-CoA synthetase, putative 0.0014 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0035 0.6421 0.6421
Trypanosoma cruzi long-chain-fatty-acid-CoA ligase, putative 0.0014 0 0.5
Toxoplasma gondii Acetyl-coenzyme A synthetase 2, putative 0.0014 0 0.5
Echinococcus granulosus acetyl coenzyme A synthetase cytoplasmic 0.0014 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0046 1 1
Loa Loa (eye worm) hypothetical protein 0.0035 0.6421 0.6421
Trichomonas vaginalis antibiotic synthetase, putative 0.0014 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Change (functional) = -22 % Percent change in renal vascular resistant e by 1.2 mg/kg of compound administered intravenously in dog ChEMBL. 2709385
Change (functional) = 0 % Percent change in mean arterial blood pressure by 1.2 mg/kg of compound administered intravenously in dog ChEMBL. 2709385
Change (functional) = 0 % Percent change in heart rate by 1.2 mg/kg of compound administered intravenously in dog ChEMBL. 2709385
Change (functional) = 28 % Percent change in renal blood flow by 1.2 mg/kg of compound administered intravenously in dog ChEMBL. 2709385

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.